Sit Investment Associates’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 548 |
|
|
2026
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 539 |
|
|
2025
Q4 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 539 |
|
|
2025
Q3 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 547 |
|
|
2025
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 546 |
|
|
2025
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 550 |
|
|
2024
Q4 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 558 |
|
|
2024
Q3 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 572 |
|
|
2024
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 556 |
|
|
2024
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 553 |
|
|
2023
Q4 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 560 |
|
|
2023
Q3 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 557 |
|
|
2023
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 561 |
|
|
2023
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 561 |
|
|
2022
Q4 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 566 |
|
|
2022
Q3 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 537 |
|
|
2022
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 540 |
|
|
2022
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 539 |
|
|
2021
Q4 | $0 | Buy |
+3,913
| New | – | ﹤0.01% | 544 |
|
|
2021
Q3 | – | Sell |
-3,913
| Closed | – | – | 550 |
|
|
2021
Q2 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 557 |
|
|
2021
Q1 | $0 | Hold |
3,913
| – | – | ﹤0.01% | 553 |
|
|
2020
Q4 | $0 | Buy |
+3,913
| New | – | ﹤0.01% | 553 |
|
Sit Investment Associates's TLOG Position: Q2 2026 in Review
Sit Investment Associates held its TetraLogic Pharmaceuticals Corporation (TLOG) position steady in Q2 2026 at 3,913 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #548.
Sit Investment Associates first reported a position in TLOG in Q4 2020 and has held it in 22 quarters since. 1 fund tracked by Wall St. Rank holds TLOG as of Q2 2026.
- Sit Investment Associates held 3,913 shares of TetraLogic Pharmaceuticals Corporation worth $0 as of Q2 2026.
- Sit Investment Associates left its TetraLogic Pharmaceuticals Corporation share count unchanged in Q2 2026.
- TetraLogic Pharmaceuticals Corporation made up ﹤0.01% of Sit Investment Associates's portfolio in Q2 2026, its #548 holding.
- Sit Investment Associates first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2020 and has held it in 22 quarters since.
- 1 fund tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q2 2026.
Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.